A scoping review of Ayurvedic rasayana adaptogens in oncology
Introduction: Rasayanas are Ayurvedic natural products that have adaptogenic effects. The extensive research on rasayanas in oncology is not currently well summarized. The aim of this review is to investigate the range and nature of the current body of research, identify gaps in knowledge, and to su...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Journal of Ayurveda and Integrative Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0975947623001961 |
_version_ | 1797262961505468416 |
---|---|
author | Cairn Wu Ashley Mulakaluri Pranay Chaurasia Sindhu Suryanarayana Ambreen Singh Nicole Krauss Peggy Tahir Charles Elder Rammanohar Puthiyedath Anand Dhruva |
author_facet | Cairn Wu Ashley Mulakaluri Pranay Chaurasia Sindhu Suryanarayana Ambreen Singh Nicole Krauss Peggy Tahir Charles Elder Rammanohar Puthiyedath Anand Dhruva |
author_sort | Cairn Wu |
collection | DOAJ |
description | Introduction: Rasayanas are Ayurvedic natural products that have adaptogenic effects. The extensive research on rasayanas in oncology is not currently well summarized. The aim of this review is to investigate the range and nature of the current body of research, identify gaps in knowledge, and to summarize the existing literature as it relates to Ayurvedic rasayanas and oncology. Materials and methods: A comprehensive literature search of fifteen Ayurvedic adaptogen rasayanas was conducted using three main concepts: Ayurvedic herbal terms, neoplasm terms, and oncological pathways. After screening was performed, key variables were extracted (tagged) including type of adaptogen, cancer type, type of study design, constituent type, and mechanisms of action (MOA). The results were synthesized and summarized using descriptive statistics and narrative summaries. Results: Five hundred and eighty-four articles were reviewed and tagged. The two most tagged adaptogens were Glycyrrhiza glabra (Yashthimadhu/licorice) (n = 166 (28.4 %)) and Withania somnifera (Ashwagandha) (n = 151 (25.9 %)). The most frequently tagged cancer diagnostic categories were gastrointestinal (n = 175 (30 %)), and breast (n = 126 (21 %)). Most of the articles focused on in vitro studies (n = 470 (80.3 %)). Of the 12 MOA tags, the most frequently tagged was apoptosis (n = 298 (29.2 %)). Conclusion: A large body of pre-clinical literature exists on adaptogen rasayanas in oncology, indicating this field of research is still in its early phase. Comparatively few studies focused on the effects on the immune system. Given the growing interest in immuno-oncology therapeutics and the potential impact of adaptogen rasayanas on the immune system, future research may focus more in this area, along with work that is more directly linked to future clinical studies. |
first_indexed | 2024-03-08T08:27:01Z |
format | Article |
id | doaj.art-fd591e6b506a4d798ff470fd78962435 |
institution | Directory Open Access Journal |
issn | 0975-9476 |
language | English |
last_indexed | 2024-04-25T00:05:26Z |
publishDate | 2024-01-01 |
publisher | Elsevier |
record_format | Article |
series | Journal of Ayurveda and Integrative Medicine |
spelling | doaj.art-fd591e6b506a4d798ff470fd789624352024-03-14T06:13:45ZengElsevierJournal of Ayurveda and Integrative Medicine0975-94762024-01-01151100879A scoping review of Ayurvedic rasayana adaptogens in oncologyCairn Wu0Ashley Mulakaluri1Pranay Chaurasia2Sindhu Suryanarayana3Ambreen Singh4Nicole Krauss5Peggy Tahir6Charles Elder7Rammanohar Puthiyedath8Anand Dhruva9Osher Center for Integrative Health, University of California, San Francisco, USAOsher Center for Integrative Health, University of California, San Francisco, USAOsher Center for Integrative Health, University of California, San Francisco, USAOsher Center for Integrative Health, University of California, San Francisco, USAOsher Center for Integrative Health, University of California, San Francisco, USAOsher Center for Integrative Health, University of California, San Francisco, USAUCSF Library, University of California, San Francisco, USAKaiser Permanente Center for Health Research, Portland, OR, USAAmrita School of Ayurveda, Amrita Visha Vidyapeetham, Kollam, Kerala, IndiaOsher Center for Integrative Health, University of California, San Francisco, USA; Department of Medicine, Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA; Corresponding author. UCSF Osher Center for Integrative Health, UCSF Box 1726, 1545 Divisadero Street, San Francisco, CA, 94143-1726, USA.Introduction: Rasayanas are Ayurvedic natural products that have adaptogenic effects. The extensive research on rasayanas in oncology is not currently well summarized. The aim of this review is to investigate the range and nature of the current body of research, identify gaps in knowledge, and to summarize the existing literature as it relates to Ayurvedic rasayanas and oncology. Materials and methods: A comprehensive literature search of fifteen Ayurvedic adaptogen rasayanas was conducted using three main concepts: Ayurvedic herbal terms, neoplasm terms, and oncological pathways. After screening was performed, key variables were extracted (tagged) including type of adaptogen, cancer type, type of study design, constituent type, and mechanisms of action (MOA). The results were synthesized and summarized using descriptive statistics and narrative summaries. Results: Five hundred and eighty-four articles were reviewed and tagged. The two most tagged adaptogens were Glycyrrhiza glabra (Yashthimadhu/licorice) (n = 166 (28.4 %)) and Withania somnifera (Ashwagandha) (n = 151 (25.9 %)). The most frequently tagged cancer diagnostic categories were gastrointestinal (n = 175 (30 %)), and breast (n = 126 (21 %)). Most of the articles focused on in vitro studies (n = 470 (80.3 %)). Of the 12 MOA tags, the most frequently tagged was apoptosis (n = 298 (29.2 %)). Conclusion: A large body of pre-clinical literature exists on adaptogen rasayanas in oncology, indicating this field of research is still in its early phase. Comparatively few studies focused on the effects on the immune system. Given the growing interest in immuno-oncology therapeutics and the potential impact of adaptogen rasayanas on the immune system, future research may focus more in this area, along with work that is more directly linked to future clinical studies.http://www.sciencedirect.com/science/article/pii/S0975947623001961Ayurvedic medicineAyurvedaAdaptogensOncologyCancerNatural products |
spellingShingle | Cairn Wu Ashley Mulakaluri Pranay Chaurasia Sindhu Suryanarayana Ambreen Singh Nicole Krauss Peggy Tahir Charles Elder Rammanohar Puthiyedath Anand Dhruva A scoping review of Ayurvedic rasayana adaptogens in oncology Journal of Ayurveda and Integrative Medicine Ayurvedic medicine Ayurveda Adaptogens Oncology Cancer Natural products |
title | A scoping review of Ayurvedic rasayana adaptogens in oncology |
title_full | A scoping review of Ayurvedic rasayana adaptogens in oncology |
title_fullStr | A scoping review of Ayurvedic rasayana adaptogens in oncology |
title_full_unstemmed | A scoping review of Ayurvedic rasayana adaptogens in oncology |
title_short | A scoping review of Ayurvedic rasayana adaptogens in oncology |
title_sort | scoping review of ayurvedic rasayana adaptogens in oncology |
topic | Ayurvedic medicine Ayurveda Adaptogens Oncology Cancer Natural products |
url | http://www.sciencedirect.com/science/article/pii/S0975947623001961 |
work_keys_str_mv | AT cairnwu ascopingreviewofayurvedicrasayanaadaptogensinoncology AT ashleymulakaluri ascopingreviewofayurvedicrasayanaadaptogensinoncology AT pranaychaurasia ascopingreviewofayurvedicrasayanaadaptogensinoncology AT sindhusuryanarayana ascopingreviewofayurvedicrasayanaadaptogensinoncology AT ambreensingh ascopingreviewofayurvedicrasayanaadaptogensinoncology AT nicolekrauss ascopingreviewofayurvedicrasayanaadaptogensinoncology AT peggytahir ascopingreviewofayurvedicrasayanaadaptogensinoncology AT charleselder ascopingreviewofayurvedicrasayanaadaptogensinoncology AT rammanoharputhiyedath ascopingreviewofayurvedicrasayanaadaptogensinoncology AT ananddhruva ascopingreviewofayurvedicrasayanaadaptogensinoncology AT cairnwu scopingreviewofayurvedicrasayanaadaptogensinoncology AT ashleymulakaluri scopingreviewofayurvedicrasayanaadaptogensinoncology AT pranaychaurasia scopingreviewofayurvedicrasayanaadaptogensinoncology AT sindhusuryanarayana scopingreviewofayurvedicrasayanaadaptogensinoncology AT ambreensingh scopingreviewofayurvedicrasayanaadaptogensinoncology AT nicolekrauss scopingreviewofayurvedicrasayanaadaptogensinoncology AT peggytahir scopingreviewofayurvedicrasayanaadaptogensinoncology AT charleselder scopingreviewofayurvedicrasayanaadaptogensinoncology AT rammanoharputhiyedath scopingreviewofayurvedicrasayanaadaptogensinoncology AT ananddhruva scopingreviewofayurvedicrasayanaadaptogensinoncology |